European neuroborreliosis: Quality of life 30months after treatment

Acta Neurologica Scandinavica

Volumn 124, Issue 5, 2011, Pages 349-354

  Eikeland, R ^a   Mygland, A ^b,c   Herlofson, K ^a   Ljostad U ^b  

^a Section for Gastroenterology   (Norway)

^b SØRLANDET HOSPITAL   (Norway)

^c UNIVERSITY OF BERGEN   (Norway)

Author keywords

Long term prognosis; Lyme disease; Neuroborreliosis; Quality of life

Indexed keywords

CEFTRIAXONE; DOXYCYCLINE;

ADULT; AGED; ANXIETY; APATHY; ARTICLE; CASE CONTROL STUDY; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; EUROPE; FATIGUE; FATIGUE SEVERITY SCALE; FEMALE; FOLLOW UP; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NEUROLOGIC DISEASE; PROSPECTIVE STUDY; QUALITY OF LIFE; SCORING SYSTEM; SHORT FORM 36; STARKSTEIN APATHY SCALE;

ADULT; AGED; CASE-CONTROL STUDIES; CLINICAL TRIALS AS TOPIC; FATIGUE; FEMALE; HUMANS; LYME NEUROBORRELIOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79952601316     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01482.x     Document Type: Article

References (29)

1. Steere AC. Lyme disease. N Engl J Med 2001;345:115-25.
2. Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-y follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002;34:421-5.
3. Pfister HW, Rupprecht TA. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients. Int J Med Microbiol 2006;296(Suppl. 40):11-6.
4. Vrethem M, Hellblom L, Widlund M et al. Chronic symptoms are common in patients with neuroborreliosis - a questionnaire follow-up study. Acta Neurol Scand 2002;106:205-8.
5. Borg R, Dotevall L, Hagberg L et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis 2005;37:449-54.
6. Ljostad U, Mygland A. Remaining complaints 1year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors. Eur J Neurol 2009;17:118-23.
7. Treib J, Fernandez A, Haass A, Grauer MT, Holzer G, Woessner R. Clinical and serologic follow-up in patients with neuroborreliosis. Neurology 1998;51:1489-91.
8. Steiner I. Treating post Lyme disease: trying to solve one equation with too many unknowns. Neurology 2003;60:1888-9.
9. Cerar D, Cerar T, Ruzic-Sabljic E, Wormser GP, Strle F. Subjective symptoms after treatment of early Lyme disease. Am J Med 2010;123:79-86.
10. Skogman BH, Croner S, Nordwall M, Eknefelt M, Ernerudh J, Forsberg P. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatr Infect Dis J 2008;27:1089-94.
11. Ljøstad U, Skogvoll E, Eikeland R et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 2008;7:690-5.
12. Krupp LB, Larocca NG, Muir-Nash J, Steinberg AD. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989;46:1121-3.
13. Lerdal A, Wahl A, Rustoen T, Hanestad BR, Moum T. Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health 2005;33:123-30.
14. Klempner MS, Hu LT, Evans J et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. [see comment]. N Eng J Med 2001;345:85-92.
15. Feder HM Jr, Johnson BJ, O'connell S et al. A critical appraisal of "chronic Lyme disease". N Engl J Med 2007;357:1422-30.
16. Shadick NA, Phillips CB, Logigian EL et al. The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med 1994;121:560-7.
17. Seltzer EG, Gerber MA, Cartter ML, Freudigman K, Shapiro ED. Long-term outcomes of persons with Lyme disease. JAMA 2000;283:609-16.
18. Shadick NA, Phillips CB, Sangha O et al. Musculoskeletal and neurologic outcomes in patients with previously treated Lyme disease. Ann Intern Med 1999;131:919-26.
19. Rupprecht TA, Koedel U, Fingerle V, Pfister HW. The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol Med 2008;14:205-12.
20. Kohlhepp W, Oschmann P, Mertens HG. Treatment of Lyme borreliosis. Randomized comparison of doxycycline and penicillin G. J Neurol 1989;236:464-9.
21. Fallon BA, Keilp JG, Corbera KM et al. A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy. Neurology 2008;70:992-1003.
22. Krupp LB, Hyman LG, Grimson R et al. Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 2003;60:1923-30.
23. Sandroni P, Walker C, Starr A. 'Fatigue' in patients with multiple sclerosis. Motor pathway conduction and event-related potentials. Arch Neurol 1992;49:517-24.
24. Herlofson K, Larsen JP. Measuring fatigue in patients with Parkinson's disease - the Fatigue Severity Scale. Eur J Neurol 2002;9:595-600.
25. Rekand T, Gramstad A, Vedeler CA. Fatigue, pain and muscle weakness are frequent after Guillain-Barre syndrome and poliomyelitis. J Neurol 2009;256:349-54.
26. Valko PO, Bassetti CL, Bloch KE, Held U, Baumann CR. Validation of the fatigue severity scale in a Swiss cohort. Sleep 2008;31:1601-7.
27. Stulemeijer M, Van Der WS, Bleijenberg G, Biert J, Brauer J, Vos PE. Recovery from mild traumatic brain injury: a focus on fatigue. J Neurol 2006;253:1041-7.
28. Hansen K, Lebech AM. The clinical and epidemiological profile of Lyme neuroborreliosis in Denmark 1985-1990. A prospective study of 187 patients with Borrelia burgdorferi specific intrathecal antibody production. Brain 1992;2:399-423.
29. Hassett AL, Radvanski DC, Buyske S et al. Role of psychiatric comorbidity in chronic Lyme disease. Arthritis Rheum 2008;59:1742-9.